TMPRSS2 and cancer: Further survival analysis was conducted with and without TMPRSS2 mutations in the pan-cancers, which demonstrated that the mutated TMPRSS2 group was significantly associated with long overall (Figure 4A), progression-free (Figure 4B), disease-specific (Figure 4C), and disease-free (Figure 4D) survival rates compared to the wild-type (WT) TMPRSS2 group (Table 1).